Visual impairment and quality of life in the older European population, the EUREYE study

Acta Ophthalmologica
Johan H SelandAstrid E Fletcher

Abstract

To determine the prevalence of visual impairment (VI) in populations 65 year or older from six European countries and describe the association with vision-related quality of life. VI was defined according to WHO as best corrected visual acuity <6/18/log MAR >0,48 (World Health Organization (1992): International Statistical Classification of Diseases and Related Health Problems, 10th revised ed. Vol 1. Geneva). 4166 participants in The European Eye study, 65 years and older selected randomly from the general census in the participating centres, were interviewed for vision-related quality of life and underwent an eye exam including distance visual acuity, refraction and fundus photography. The prevalence of VI rose with increasing age and more so in women. There was a pattern of a higher prevalence of VI in the Mediterranean countries compared to Northern European countries with the exception of Tallinn (Estonia) which had higher VI prevalence rates than the other north European centres. The prevalence of low vision was 3% or less in all centres. Blindness prevalence varied from 2% to less than half a per cent. Vision-related quality of life was strongly associated with visual acuity and the presence of bilateral age-related macu...Continue Reading

References

Aug 1, 1991·Ophthalmology·R KleinD L De Mets
Jul 1, 1982·American Journal of Ophthalmology·F L FerrisI Bailey
Feb 3, 2000·The British Journal of Ophthalmology·J C van der PolsS Finch
Mar 23, 2001·Ophthalmic Epidemiology·I Abou-GareebP Courtright
Jun 27, 2001·Survey of Ophthalmology·R W Massof, G S Rubin
Jul 27, 2001·Archives of Ophthalmology·C M MangioneUNKNOWN National Eye Institute Visual Function Questionnaire Field Test Investigators
Feb 24, 2004·The British Journal of Ophthalmology·J R EvansUNKNOWN MRC Trial of Assessment and Management of Older People in the Community
Apr 14, 2004·Archives of Ophthalmology·Nathan CongdonUNKNOWN Eye Diseases Prevalence Research Group
May 19, 2004·The British Journal of Ophthalmology·A FotouhiUNKNOWN Tehran Eye Study
Apr 12, 2006·Archives of Ophthalmology·Cristina A AugoodAstrid E Fletcher
Jan 16, 2007·American Journal of Ophthalmology·Hugh R TaylorJill E Keeffe

❮ Previous
Next ❯

Citations

Apr 25, 2012·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·K Rohrschneider
Sep 11, 2012·Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)·Joan A StelmackUNKNOWN LOVIT II Study Group
Jan 1, 2010·Journal of Nutritional Science and Vitaminology·Thirumurthy VelpandianSupriyo Ghose
Mar 5, 2016·Disability and Rehabilitation·Rainer SchliermannVolker Anneken
Dec 22, 2015·European Journal of Epidemiology·Cécile DelcourtCaroline C W Klaver
Jan 3, 2013·Acta Ophthalmologica·Saskia M MacaTalin Barisani-Asenbauer
May 15, 2012·Acta Ophthalmologica·Haakon Lindekleiv, Maja Gran Erke
May 12, 2017·Health and Quality of Life Outcomes·Ellen Bernadette Maria ElsmanGerardus Hermanus Maria Bartholomeus van Rens
Oct 4, 2014·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Janna E BruijningRuth M A van Nispen
Jun 27, 2013·Journal of Primary Care & Community Health·José A Pagán, Erin K Carlson
Feb 7, 2018·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Ya-Chuan TsengGuey-Shiun Huang
Jul 13, 2019·Health and Quality of Life Outcomes·Razieh BandariAli Montazeri
Jun 19, 2018·Frontiers in Neurology·W Pieter MedendorpLuc P J Selen
Apr 28, 2018·Scientific Reports·Bénédicte M J MerleCécile Delcourt
Nov 7, 2019·Journal of Ophthalmology·Benjamin D NuerteyRichard Bekoe Biritwum
Aug 28, 2019·NPJ Digital Medicine·Wai Kent YeungIracema Leroi
Jan 15, 2021·Translational Vision Science & Technology·William MitchellNazlee Zebardast
Aug 28, 2021·Disability and Rehabilitation·Debbie BoeyLeeanne Carey
Dec 24, 2021·Indian Journal of Ophthalmology·Kholoud Ahmad BokharyRania Fahmy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Archives of Ophthalmology
David S FriedmanEye Diseases Prevalence Research Group
The New England Journal of Medicine
Paulus T V M de Jong
Investigative Ophthalmology & Visual Science
Michael DorrPeter J Bex
© 2022 Meta ULC. All rights reserved